Article
CYP2C9 gene and susceptibility to major depressive disorder.
The pharmacogenomics journal - 1 Jan 2003
LLerena A, Berecz R, Dorado P, González A P, Peñas-LLedó E M, De La Rubia A
Abstract excerpt
Alteration of monoaminergic neurotransmission has been implicated in the pathophysiology of mood disorders, and CYP2C9 enzyme activity has been shown to be modulated by serotonin in vitro. The present study was aimed at analysing the frequency of CYP2C9 alleles (*1, *2, *3) among patients suffering from major depressive disorder. In all, 70 such suffering psychiatric outpatients were studied. The CYP2C9 genotypes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
